Literature DB >> 27493274

Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine.

Gregory T Collins1, Megan Abbott2, Kayla Galindo2, Elise L Rush2, Kenner C Rice2, Charles P France2.   

Abstract

Illicit drug preparations often include more than one pharmacologically active compound. For example, cocaine and synthetic cathinones [e.g., 3,4-methylenedioxypyrovalerone (MDPV)] are often mixed with caffeine before sale. Caffeine is likely added to these preparations because it is inexpensive and legal; however, caffeine might also mimic or enhance some of the effects of cocaine or MDPV. In these studies, male Sprague-Dawley rats were trained to discriminate 10 mg/kg cocaine from saline, and the discriminative stimulus effects of cocaine, caffeine, and MDPV were evaluated alone and as binary mixtures (cocaine and caffeine, MDPV and caffeine, and cocaine and MDPV) at fixed-dose ratios of 3:1, 1:1, and 1:3 relative to the dose of each drug that produced 50% cocaine-appropriate responding. Dose-addition analyses were used to determine the nature of the drug-drug interactions for each mixture (e.g., additive, supra-additive, or subadditive). Although additive interactions were observed for most mixtures, supra-additive interactions were observed at the 50% effect level for the 1:1 mixture of cocaine and caffeine and at the 80% effect level for all three mixtures of cocaine and caffeine, as well as for the 3:1 and 1:3 mixtures of cocaine and MDPV. These results demonstrate that with respect to cocaine-like discriminative stimulus effects, caffeine can function as a substitute in drug preparations containing either cocaine or MDPV, with enhancements of cocaine-like effects possible under certain conditions. Further research is needed to determine whether similar interactions exist for other abuse-related or toxic effects of drug preparations, including cocaine, synthetic cathinones, and caffeine. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27493274      PMCID: PMC5034708          DOI: 10.1124/jpet.116.234252

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  47 in total

1.  Caffeine enhances and accelerates the expression of sensitization induced by coca paste indicating its relevance as a main adulterant.

Authors:  José P Prieto; Martín Galvalisi; Ximena López-Hill; María N Meikle; Juan A Abin-Carriquiry; Cecilia Scorza
Journal:  Am J Addict       Date:  2015-05-14

2.  Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010-2012).

Authors:  Fernando Caudevilla-Gálligo; Mireia Ventura; Blanca Iciar Indave Ruiz; Iván Fornís
Journal:  Hum Psychopharmacol       Date:  2013-07       Impact factor: 1.672

3.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

4.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

5.  Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose.

Authors:  M Gasior; M Jaszyna; J Peters; S R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

6.  Caffeine preexposure sensitizes rats to the motor activating effects of cocaine.

Authors:  S. Schenk; B. Horger; S. Snow
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

7.  Self-administration of drug mixtures by monkeys: combining drugs with comparable mechanisms of action.

Authors:  W L Woolverton; Zhixia Wang; Theresa Vasterling; F Ivy Carroll; Ronald Tallarida
Journal:  Psychopharmacology (Berl)       Date:  2007-11-20       Impact factor: 4.530

8.  Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat.

Authors:  G K Mumford; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1991-09       Impact factor: 4.030

9.  Cocaine-induced hyperactivity is more influenced by adenosine receptor agonists than amphetamine-induced hyperactivity.

Authors:  Ewa Poleszak; Danuta Malec
Journal:  Pol J Pharmacol       Date:  2002 Jul-Aug

10.  Evaluation of the composition of street cocaine seized in two regions of Brazil.

Authors:  Elisângela Jaqueline Magalhães; Clésia C Nascentes; Leandro S A Pereira; Mário L O Guedes; Rogério A Lordeiro; Lúcia M L A Auler; Rodinei Augusti; Maria Eliana L R de Queiroz
Journal:  Sci Justice       Date:  2013-06-20       Impact factor: 2.124

View more
  19 in total

1.  Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.

Authors:  Gregory T Collins; Charles P France
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-28       Impact factor: 3.157

2.  Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Authors:  Brenda M Gannon; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Psychopharmacology (Berl)       Date:  2018-09-29       Impact factor: 4.530

3.  Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

4.  Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Authors:  Gregory T Collins; Agnieszka Sulima; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2019-07-26       Impact factor: 4.530

5.  Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Kenner C Rice; Gregory T Collins
Journal:  J Pharmacol Exp Ther       Date:  2017-02-08       Impact factor: 4.030

6.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

7.  Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.

Authors:  Brenda M Gannon; Adrian Williamson; Kenner C Rice; William E Fantegrossi
Journal:  Neuropharmacology       Date:  2017-09-05       Impact factor: 5.250

8.  Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Melson P Mesmin; Kenner C Rice; Gregory T Collins
Journal:  Neuropsychopharmacology       Date:  2017-07-05       Impact factor: 7.853

9.  Reinforcing effects of abused 'bath salts' constituents 3,4-methylenedioxypyrovalerone and α-pyrrolidinopentiophenone and their enantiomers.

Authors:  Brenda M Gannon; Kenner C Rice; Gregory T Collins
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

10.  The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.

Authors:  Brenda M Gannon; Michael H Baumann; Donna Walther; Cristian Jimenez-Morigosa; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropsychopharmacology       Date:  2018-09-10       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.